tiprankstipranks
Advertisement
Advertisement

AMGN Stock Latest News

European Commission approves Amgen’s Imdylltra for ES-SCLC
The FlyEuropean Commission approves Amgen’s Imdylltra for ES-SCLC
2d ago
AMGN
Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study
PremiumCompany Announcements
Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study
12d ago
AMGN
Amgen Shareholders Reaffirm Board, Pay and Auditors
PremiumCompany Announcements
Amgen Shareholders Reaffirm Board, Pay and Auditors
14d ago
8K
AMGN
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer
PremiumCompany Announcements
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer
14d ago
AMGN
Amgen Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
Amgen Earnings Call Highlights Growth Amid Headwinds
15d ago
AMGN
Amgen Announces CFO Transition and Leadership Succession Plan
PremiumCompany AnnouncementsAmgen Announces CFO Transition and Leadership Succession Plan
15d ago
8K
AMGN
Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed
Premium
The Fly
Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed
15d ago
AMGN
Amgen price target lowered to $427 from $432 at Piper Sandler
Premium
The Fly
Amgen price target lowered to $427 from $432 at Piper Sandler
20d ago
AMGN
The Week That Was, The Week Ahead: Macro and Markets, May 10
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, May 10
24d ago
F
V
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
PremiumMarket News
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
25d ago
BLK
IBB
Honeywell-Backed Quantinuum Files for IPO amid Quantum Computing Excitement
PremiumMarket News
Honeywell-Backed Quantinuum Files for IPO amid Quantum Computing Excitement
26d ago
HON
AMGN
Amgen Halts Phase 2 HZN-1116 Trial in Sjögren’s: What Investors Should Know
PremiumCompany Announcements
Amgen Halts Phase 2 HZN-1116 Trial in Sjögren’s: What Investors Should Know
26d ago
AMGN
Amgen upgraded to Buy from Hold at Freedom Broker
PremiumThe FlyAmgen upgraded to Buy from Hold at Freedom Broker
27d ago
AMGN
Amgen downgraded to Hold from Buy at Erste Group
Premium
The Fly
Amgen downgraded to Hold from Buy at Erste Group
29d ago
AMGN
Erste downgrades Amgen on declining sales growth
Premium
The Fly
Erste downgrades Amgen on declining sales growth
29d ago
AMGN
Amgen to invest additional $300M in U.S. manufacturing network
PremiumThe Fly
Amgen to invest additional $300M in U.S. manufacturing network
1M ago
AMGN
Amgen price target lowered to $340 from $351 at Guggenheim
PremiumThe Fly
Amgen price target lowered to $340 from $351 at Guggenheim
1M ago
AMGN
Amgen Earnings Call Highlights Growth Engines, Tax Risk
PremiumCompany Announcements
Amgen Earnings Call Highlights Growth Engines, Tax Risk
1M ago
AMGN
Analyst Reiterates Buy on Amgen After Strong Q1 2026, Raised Guidance and Growing Confidence in MariTide Pipeline
PremiumRatings
Analyst Reiterates Buy on Amgen After Strong Q1 2026, Raised Guidance and Growing Confidence in MariTide Pipeline
1M ago
AMGN
Amgen Price Target Raised to $425 as Strong Execution and Expanding Pipeline Underpin Maintained Buy Rating
PremiumRatingsAmgen Price Target Raised to $425 as Strong Execution and Expanding Pipeline Underpin Maintained Buy Rating
1M ago
AMGN
Amgen price target raised to $307 from $304 at BofA
Premium
The Fly
Amgen price target raised to $307 from $304 at BofA
1M ago
AMGN
Amgen price target raised to $332 from $326 at Morgan Stanley
Premium
The Fly
Amgen price target raised to $332 from $326 at Morgan Stanley
1M ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >